Leqembi Granted Full FDA Approval to Treat Early Alzheimer's Disease
Lecanemab was shown to slow cognitive decline in early Alzheimer’s disease and reduce the number of amyloid plaques.
Source: everydayhealth.com
Fast, Ad-Free News Updates
Stay updated with breaking news from Outweigh Risks. Real-time updates on events, politics, business and more.